1、 Corrected Transcript 1-877-FACTSET Total Pages:22 Copyright 2001-2025 FactSet CallStreet,LLC 30-Jul-2025 Teva Pharmaceutical Industries Ltd.(TEVA)Q2 2025 Earnings Call Teva Pharmaceutical Industries Ltd.(TEVA)Q2 2025 Earnings Call Corrected Transcript 30-Jul-2025 1-877-FACTSET 2 Copyright 2001-2025

2、 FactSet CallStreet,LLC CORPORATE PARTICIPANTS Christopher J.Stevo Senior Vice President-Investor Relations&Competitive Intelligence,Teva Pharmaceutical Industries Ltd.Richard Francis President,Chief Executive Officer&Director,Teva Pharmaceutical Industries Ltd.Eric A.Hughes Executive Vice President

3、,Global R&D and Chief Medical Officer,Teva Pharmaceutical Industries Ltd.Eli Kalif Executive Vice President&Chief Financial Officer,Teva Pharmaceutical Industries Ltd.OTHER PARTICIPANTS Ashwani Verma Analyst,UBS Securities LLC Matt Dellatorre Analyst,Goldman Sachs&Co.LLC Jason M.Gerberry Analyst,Bof

4、A Securities,Inc.David Amsellem Analyst,Piper Sandler&Co.Chris Schott Analyst,JPMorgan Securities LLC Les Sulewski Analyst,Truist Securities,Inc.Keonhee Kim Analyst,Morningstar,Inc.(Research).MANAGEMENT DISCUSSION SECTION Operator:Hello and welcome to the Teva Pharmaceutical Industries Limited Q2 20

5、25 Earnings Conference Call.My name is Alex.Ill be coordinating the call for today.Operator Instructions Ill now hand it over to Chris Stevo,SVP,Investor Relations.Please go ahead.Christopher J.Stevo Senior Vice President-Investor Relations&Competitive Intelligence,Teva Pharmaceutical Industries Ltd

6、.Thank you,Alex.Good morning and good afternoon,everyone.On this call,well be making forward-looking statements and we disclaim any obligation to update those statements after todays call.If you have more questions about our forward-looking statements,please feel free to see our disclosures under SE